carnitine has been researched along with Sarcopenia in 13 studies
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with carnitine insufficiency had a significantly higher prevalence of muscle weakness and a lower 6-min walk distance than those without carnitine insufficiency (P < 0." | 8.31 | Association of carnitine insufficiency with sarcopenia and dynapenia in patients with heart failure. ( Hirai, M; Kato, M; Kinugasa, Y; Nakamura, K; Sota, T; Yamamoto, K, 2023) |
| "This study suggests that carnitine level is a biomarker of sarcopenia and nutritional status." | 8.12 | Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients. ( Hawke, P; Higashizono, K; Kanemoto, H; Nagai, E; Nakatani, E; Oba, N; Takagi, A; Toda, T; Tokuda, S; Watanabe, M, 2022) |
| " This study highlights the potential roles of acylcarnitines and LPCs in sarcopenia and its components, which may provide valuable information regarding the pathogenesis and management of sarcopenia." | 8.12 | Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men. ( Dang, Y; Dong, J; Fan, G; Meng, L; Shen, J; Shi, H; Shi, J; Wang, D; Wu, W; Xi, H; Yang, R; Yu, P, 2022) |
| "This study investigated the inhibitory effect of levocarnitine supplementation on sarcopenia progression in hepatocellular carcinoma (HCC) patients treated with lenvatinib." | 8.02 | Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. ( Ando, H; Ikejima, K; Nagahara, A; Nakadera, E; Okubo, H; Shiina, S, 2021) |
| "The aim of this study was to elucidate the efficacy of the combination of L-carnitine and exercise, reported to prevent muscle wasting, for muscle complications (function, volume, and cramping) in patients with liver cirrhosis (LC) who received branched-chain amino acid supplementation." | 7.91 | Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation? ( Abe, M; Hiasa, Y; Hiraoka, A; Hirooka, M; Kiguchi, D; Matsuura, B; Michitaka, K; Ninomiya, T, 2019) |
| "Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC)." | 5.56 | Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. ( Abe, K; Fujita, M; Hayashi, M; Ohira, H; Takahashi, A, 2020) |
| "Patients with carnitine insufficiency had a significantly higher prevalence of muscle weakness and a lower 6-min walk distance than those without carnitine insufficiency (P < 0." | 4.31 | Association of carnitine insufficiency with sarcopenia and dynapenia in patients with heart failure. ( Hirai, M; Kato, M; Kinugasa, Y; Nakamura, K; Sota, T; Yamamoto, K, 2023) |
| "This study suggests that carnitine level is a biomarker of sarcopenia and nutritional status." | 4.12 | Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients. ( Hawke, P; Higashizono, K; Kanemoto, H; Nagai, E; Nakatani, E; Oba, N; Takagi, A; Toda, T; Tokuda, S; Watanabe, M, 2022) |
| " This study highlights the potential roles of acylcarnitines and LPCs in sarcopenia and its components, which may provide valuable information regarding the pathogenesis and management of sarcopenia." | 4.12 | Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men. ( Dang, Y; Dong, J; Fan, G; Meng, L; Shen, J; Shi, H; Shi, J; Wang, D; Wu, W; Xi, H; Yang, R; Yu, P, 2022) |
| "This study investigated the inhibitory effect of levocarnitine supplementation on sarcopenia progression in hepatocellular carcinoma (HCC) patients treated with lenvatinib." | 4.02 | Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. ( Ando, H; Ikejima, K; Nagahara, A; Nakadera, E; Okubo, H; Shiina, S, 2021) |
| "The aim of this study was to elucidate the efficacy of the combination of L-carnitine and exercise, reported to prevent muscle wasting, for muscle complications (function, volume, and cramping) in patients with liver cirrhosis (LC) who received branched-chain amino acid supplementation." | 3.91 | Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation? ( Abe, M; Hiasa, Y; Hiraoka, A; Hirooka, M; Kiguchi, D; Matsuura, B; Michitaka, K; Ninomiya, T, 2019) |
| "Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC)." | 1.56 | Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. ( Abe, K; Fujita, M; Hayashi, M; Ohira, H; Takahashi, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 9 (69.23) | 2.80 |
| Authors | Studies |
|---|---|
| Bin-Jumah, MN | 1 |
| Gilani, SJ | 1 |
| Hosawi, S | 1 |
| Al-Abbasi, FA | 1 |
| Zeyadi, M | 1 |
| Imam, SS | 1 |
| Alshehri, S | 1 |
| Ghoneim, MM | 1 |
| Nadeem, MS | 1 |
| Kazmi, I | 1 |
| Takagi, A | 1 |
| Hawke, P | 1 |
| Tokuda, S | 1 |
| Toda, T | 1 |
| Higashizono, K | 1 |
| Nagai, E | 1 |
| Watanabe, M | 1 |
| Nakatani, E | 1 |
| Kanemoto, H | 1 |
| Oba, N | 1 |
| Okubo, H | 1 |
| Ando, H | 1 |
| Nakadera, E | 1 |
| Ikejima, K | 1 |
| Shiina, S | 1 |
| Nagahara, A | 1 |
| Meng, L | 1 |
| Yang, R | 1 |
| Wang, D | 1 |
| Wu, W | 1 |
| Shi, J | 1 |
| Shen, J | 1 |
| Dang, Y | 1 |
| Fan, G | 1 |
| Shi, H | 1 |
| Dong, J | 1 |
| Xi, H | 1 |
| Yu, P | 1 |
| Murata, K | 1 |
| Kaji, K | 1 |
| Nishimura, N | 1 |
| Enomoto, M | 1 |
| Fujimoto, Y | 1 |
| Takeda, S | 1 |
| Tsuji, Y | 1 |
| Fujinaga, Y | 1 |
| Takaya, H | 1 |
| Kawaratani, H | 1 |
| Namisaki, T | 1 |
| Akahane, T | 1 |
| Yoshiji, H | 1 |
| Kinugasa, Y | 1 |
| Sota, T | 1 |
| Nakamura, K | 1 |
| Hirai, M | 1 |
| Kato, M | 1 |
| Yamamoto, K | 1 |
| Fujita, M | 1 |
| Abe, K | 1 |
| Hayashi, M | 1 |
| Takahashi, A | 1 |
| Ohira, H | 1 |
| Sawicka, AK | 1 |
| Renzi, G | 1 |
| Olek, RA | 1 |
| Ng, TKS | 1 |
| Kovalik, JP | 1 |
| Ching, J | 1 |
| Chan, AW | 1 |
| Matchar, DB | 1 |
| Zhang, N | 1 |
| Valentine, JM | 1 |
| Zhou, Y | 1 |
| Li, ME | 1 |
| Zhang, Y | 1 |
| Bhattacharya, A | 1 |
| Walsh, ME | 1 |
| Fischer, KE | 1 |
| Austad, SN | 1 |
| Osmulski, P | 1 |
| Gaczynska, M | 1 |
| Shoelson, SE | 1 |
| Van Remmen, H | 1 |
| Chen, HI | 1 |
| Chen, Y | 1 |
| Liang, H | 1 |
| Musi, N | 1 |
| Fielding, R | 1 |
| Riede, L | 1 |
| Lugo, JP | 1 |
| Bellamine, A | 1 |
| Hiraoka, A | 1 |
| Kiguchi, D | 1 |
| Ninomiya, T | 1 |
| Hirooka, M | 1 |
| Abe, M | 1 |
| Matsuura, B | 1 |
| Hiasa, Y | 1 |
| Michitaka, K | 1 |
| Nishikawa, H | 1 |
| Osaki, Y | 1 |
4 reviews available for carnitine and Sarcopenia
| Article | Year |
|---|---|
Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients.
Topics: Biodiversity; Biomarkers; Carnitine; Choline; Dietary Supplements; Disease Susceptibility; Dysbiosis | 2021 |
The bright and the dark sides of L-carnitine supplementation: a systematic review.
Topics: Age Factors; Body Composition; Carnitine; Cognition; Dietary Carbohydrates; Dietary Supplements; Ene | 2020 |
l-Carnitine Supplementation in Recovery after Exercise.
Topics: Adult; Aged; Antioxidants; Carnitine; Dietary Supplements; Elder Nutritional Physiological Phenomena | 2018 |
Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.
Topics: Carcinoma, Hepatocellular; Carnitine; Electric Impedance; Fibrosis; Hand Strength; Hepatitis C, Chro | 2015 |
9 other studies available for carnitine and Sarcopenia
| Article | Year |
|---|---|
Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients.
Topics: Biomarkers; Carnitine; Gastrointestinal Neoplasms; Humans; Male; Nutritional Status; Sarcopenia | 2022 |
Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Carnitine; Dietary Supplements; Female; Humans; | 2021 |
Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men.
Topics: Aged; Amino Acids; Carnitine; Cross-Sectional Studies; Female; Hand Strength; Humans; Lysophosphatid | 2022 |
Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.
Topics: Animals; Carnitine; Lipopolysaccharides; Liver Cirrhosis; Muscle, Skeletal; Muscular Atrophy; Rats; | 2022 |
Association of carnitine insufficiency with sarcopenia and dynapenia in patients with heart failure.
Topics: Carnitine; Hand Strength; Heart Failure; Humans; Muscle Strength; Muscle Weakness; Muscle, Skeletal; | 2023 |
Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Carnitine; Female; Humans; Liver Cirrhosis; Male; Middle Ag | 2020 |
Novel metabolomics markers are associated with pre-clinical decline in hand grip strength in community-dwelling older adults.
Topics: Aged; Aging; Asymptomatic Diseases; Biomarkers; Carnitine; Energy Metabolism; Fatty Acids; Female; F | 2021 |
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle health.
Topics: Aging; Animals; Blood Glucose; Carnitine; Cell Line; Ceramides; Female; Gene Expression Regulation; | 2017 |
Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Topics: Aged; Amino Acids, Branched-Chain; Carnitine; Dietary Supplements; Electric Impedance; Exercise Ther | 2019 |